The board of directors of Bristol-Myers Squibb Company (NYSE:BMY), a biopharmaceutical company, declared a quarterly dividend of USD0.45 per share on the company's USD0.10 par value common stock, it disclosed on Tuesday.
This next quarterly common stock dividend is due on 1 May 2020 to stockholders of record at the close of business as of 3 April 2020.
Additionally, the board declared a quarterly dividend of USD0.50 per share on Bristol-Myers Squibb's USD2.00 convertible preferred stock.
Stockholders of record at the close of business as of 5 May 2020 will receive the preferred stock dividend on 1 June 2020 to
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development